deltatrials
Completed OBSERVATIONAL NCT02188095

Post Market Clinical Follow-Up Study of Excia T® Hip Prosthesis

Sponsor: Aesculap AG

Conditions Hip Arthritis
Updated 19 times since 2017 Last updated: Feb 27, 2026 Started: Sep 3, 2014 Primary completion: Oct 6, 2015 Completion: Nov 7, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Hip Arthritis and is currently completed. Aesculap AG leads this study, which shows 19 recorded versions since 2014 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Mar 2018 · 14 months · monthly snapshot~Mar 2018 – ~Apr 2018 · 31 days · monthly snapshot~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshot~Jun 2018 – ~Oct 2018 · 4 months · monthly snapshot~Oct 2018 – ~Nov 2019 · 13 months · monthly snapshot~Nov 2019 – ~Nov 2020 · 12 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshot~Dec 2021 – ~Apr 2022 · 4 months · monthly snapshot~Apr 2022 – ~Sep 2022 · 5 months · monthly snapshot~Sep 2022 – ~Aug 2023 · 11 months · monthly snapshot~Aug 2023 – ~Sep 2023 · 31 days · monthly snapshot~Sep 2023 – ~Jul 2024 · 10 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Nov 2024 · 2 months · monthly snapshot~Nov 2024 – ~Nov 2025 · 12 months · monthly snapshot~Nov 2025 – ~Feb 2026 · 3 months · monthly snapshot~Feb 2026 – ~Mar 2026 · 28 days · monthly snapshot~Mar 2026 – present · 4 months · monthly snapshot

Change History

19 versions recorded
  1. Mar 2026 — Present [monthly]

    Completed

    Status: Active Not RecruitingCompleted

  2. Feb 2026 — Mar 2026 [monthly]

    Active Not Recruiting

  3. Nov 2025 — Feb 2026 [monthly]

    Active Not Recruiting

  4. Nov 2024 — Nov 2025 [monthly]

    Active Not Recruiting

  5. Sep 2024 — Nov 2024 [monthly]

    Active Not Recruiting

Show 14 earlier versions
  1. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting

  2. Sep 2023 — Jul 2024 [monthly]

    Active Not Recruiting

  3. Aug 2023 — Sep 2023 [monthly]

    Active Not Recruiting

  4. Sep 2022 — Aug 2023 [monthly]

    Active Not Recruiting

  5. Apr 2022 — Sep 2022 [monthly]

    Active Not Recruiting

  6. Dec 2021 — Apr 2022 [monthly]

    Active Not Recruiting

  7. Jan 2021 — Dec 2021 [monthly]

    Active Not Recruiting

  8. Nov 2020 — Jan 2021 [monthly]

    Active Not Recruiting

  9. Nov 2019 — Nov 2020 [monthly]

    Active Not Recruiting

  10. Oct 2018 — Nov 2019 [monthly]

    Active Not Recruiting

  11. Jun 2018 — Oct 2018 [monthly]

    Active Not Recruiting

  12. Apr 2018 — Jun 2018 [monthly]

    Active Not Recruiting

    Phase: NANone

  13. Mar 2018 — Apr 2018 [monthly]

    Active Not Recruiting NA

  14. Jan 2017 — Mar 2018 [monthly]

    Active Not Recruiting NA

    First recorded

Sep 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Aesculap AG
Data source: Aesculap AG

For direct contact, visit the study record on ClinicalTrials.gov .